Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 17
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Amyloid deposition in adults with drug-resistant temporal lobe epilepsy

  • Fonseca, Elena|||0000-0002-3895-1237
  • Lallana, Sofía|||0000-0002-5999-9889
  • Ortega, Gemma
  • Cano, Amanda|||0000-0001-9567-4283
  • Sarria Estrada, Silvana|||0000-0003-0083-362X
  • Pareto, Deborah|||0000-0001-7356-3769
  • Quintana, Manuel|||0000-0003-0288-9088
  • Lorenzo Bosquet, Carles|||0000-0002-8824-4602
  • López Maza, Samuel|||0000-0003-3660-2604
  • Gifreu, Ariadna
  • Campos Fernández, Daniel|||0000-0003-4795-5309
  • Abraira del Fresno, Laura|||0000-0002-5119-7929
  • Santamarina Perez, Estevo|||0000-0003-1915-0335
  • Orellana del Río, Adelina|||0000-0002-0204-1944
  • Montrreal Navarro, Laura|||0000-0002-0010-645X
  • Puerta, Raquel|||0000-0002-1191-5893
  • Aguilera, Núria
  • Ramis, Maribel
  • De Rojas, Itziar|||0000-0002-2148-381X
  • Ruiz Laza, Agustín|||0000-0003-2633-2495
  • Tárraga, Lluís|||0000-0002-8423-946X
  • Rovira, Alex|||0000-0002-2132-6750
  • Marquié, Marta|||0000-0002-0660-0950
  • Boada, Mercè|||0000-0003-2617-3009
  • Toledo, Manuel|||0000-0003-1550-3316
Objective: Pathological amyloid-β (Aβ) accumulation and hyperphosphorylated tau proteins have been described in resected temporal lobe specimens of epilepsy patients. We aimed to determine cerebrospinal fluid (CSF) Aβ1-42 and p181-tau levels and cerebral Aβ deposits on positron emission tomography (Aβ PET) and correlate these findings with cognitive performance in adults with drug-resistant temporal lobe epilepsy (TLE). Methods: In this cross-sectional study, we enrolled individuals with drug-resistant TLE who were 25-55 years old. Each participant underwent F-flutemetamol PET, determination of CSF Aβ1-42, p181-tau, and total tau, and a comprehensive neuropsychological assessment. We evaluated normalized standard uptake value ratios (SUVRs) for different brain regions on Aβ PET. Results: Thirty patients (mean age = 41.9 ± SD 8.1 years, 57% men) were included. The median disease duration was 9.5 (interquartile range = 4-24) years. Twenty-six patients (87%) had a clinically significant cognitive impairment on neuropsychological evaluation, 18 (69%) of the amnesic type. On Aβ PET, high uptake was observed in both mesial temporal regions (ipsilateral: SUVR z-score =.90, 95% confidence interval [CI] =.60-1.20; contralateral: SUVR z-score =.92, 95% CI =.57-1.27; p <.001), which was higher when compared to SUVR z-scores in all the remaining regions (p <.001) and in the ipsilateral anterior cingulate (SUVR z-score =.27, 95% CI =.04-.49, p =.020). No significant deposition was observed in other regions. Seven patients (23%) had low Aβ1-42 levels, and two (7%) had elevated p181-tau levels in CSF. Higher p181-tau levels correlated with poorer verbal fluency (R = -.427, p =.044). Significance: Our findings reveal a considerable Aβ deposition in mesial temporal regions and ipsilateral anterior cingulate among adults with drug-resistant TLE. Additionally, abnormal CSF Aβ1-42 levels were observed in a significant proportion of patients, and p181-tau levels were associated with verbal fluency. These results suggest that markers of neuronal damage can be observed in adults with TLE, warranting further investigation.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Mendelian Randomisation Confirms the Role of Y-Chromosome Loss in Alzheimer’s Disease Aetiopathogenesis in Men

  • García-González, Pablo
  • Rojas, Itziar de
  • Moreno-Grau, Sonia
  • Montrreal, Laura
  • Puerta, Raquel
  • Alarcón-Martín, Emilio
  • Quintela, Inés
  • Orellana, Adela
  • Andrade, Victor
  • Martino-Adami, Pamela V.
  • Heilmann-Heimbach, Stefanie
  • Gómez-Garre, Pilar
  • Periñán, María Teresa
  • Álvarez, Ignacio
  • Díez-Fairen, Mónica
  • Nuñez-Llaves, Raul
  • Olivé-Roig, Claudia
  • García-Ribas, Guillermo
  • Menéndez-González, Manuel
  • Martínez, Carmen
  • Aguilar Barberá, Miquel
  • Buongiorno, Maria Teresa
  • Franco-Macías, Emilio
  • Sáez, María Eugenia
  • Cano, Amanda
  • Bullido, María Jesús
  • Real, Luis Miguel
  • Rodríguez-Rodríguez, Eloy
  • Royo, José Luis
  • Álvarez, Victoria
  • Pastor, Pau
  • Piñol-Ripoll, Gerard
  • Mir, Pablo
  • Calero, Miguel
  • Medina-Padilla, Miguel
  • Sánchez-Juan, Pascual
  • Carracedo, Ángel
  • Valero, Sergi
  • Hernández, Isabel
  • Tárraga, Lluís
  • Ramírez, Alfredo
  • Boada, Mercè
  • Ruiz, Agustín
Mosaic loss of chromosome Y (mLOY) is a common ageing-related somatic event and has been previously associated with Alzheimer’s disease (AD). However, mLOY estimation from genotype microarray data only reflects the mLOY degree of subjects at the moment of DNA sampling. Therefore, mLOY phenotype associations with AD can be severely age-confounded in the context of genome-wide association studies. Here, we applied Mendelian randomisation to construct an age-independent mLOY polygenic risk score (mloy-PRS) using 114 autosomal variants. The mloy-PRS instrument was associated with an 80% increase in mLOY risk per standard deviation unit (p = 4.22 × 10−20) and was orthogonal with age. We found that a higher genetic risk for mLOY was associated with faster progression to AD in men with mild cognitive impairment (hazard ratio (HR) = 1.23, p = 0.01). Importantly, mloy-PRS had no effect on AD conversion or risk in the female group, suggesting that these associations are caused by the inherent loss of the Y chromosome. Additionally, the blood mLOY phenotype in men was associated with increased cerebrospinal fluid levels of total tau and phosphorylated tau181 in subjects with mild cognitive impairment and dementia. Our results strongly suggest that mLOY is involved in AD pathogenesis., P.G.-G. (Pablo García-González) is supported by CIBERNED employment plan CNV-304-PRF-866. CIBERNED is integrated into ISCIII (Instituto de Salud Carlos III). I.d.R is supported by a national grant from the Instituto de Salud Carlos III FI20/00215. A.C. (Amanda Cano) acknowledges the support of the Spanish Ministry of Science, Innovation, and Universities under the grant Juan de la Cierva (FJC2018-036012-I). M.B. (Mercé Boada) and A.R. (Agustín Ruiz) are also supported by national grants PI13/02434, PI16/01861, PI17/01474, PI19/01240, and PI19/01301. The Genome Research @ Fundació ACE project (GR@ACE) is supported by Grifols SA, Fundación bancaria “La Caixa”, Fundació ACE, and CIBERNED. Acción Estratégica en Salud is integrated into the Spanish National R + D + I Plan and funded by ISCIII (Instituto de Salud Carlos III)—Subdirección General de Evaluación—and the Fondo Europeo de Desarrollo Regional (FEDER—“Una manera de hacer Europa”). Genotyping of the ACE MCI-EADB samples was performed in the context of EADB (European Alzheimer DNA biobank) funded by the JPco-fuND FP-829-029 (ZonMW project number 733051061). This work was supported by a grant (European Alzheimer DNA BioBank, EADB) from the EU Joint Program—Neurodegenerative Disease Research (JPND)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Otros (Other)

Connecting genomic and proteomic signatures of amyloid burden in the brain

  • Puerta, Raquel
  • de Rojas, Itziar
  • García-González, Pablo
  • Olivé-Roig, Claudia
  • Sotolongo-Grau, Oscar
  • García-Sánchez, Ainhoa
  • García-Gutiérrez, Fernando
  • Montrreal, Laura
  • Tartari, Juan Pablo
  • Sanabria, Ángela
  • Pytel, Vanesa
  • Lage, Carmen
  • Quintela, Ines
  • Aguilera, Nuria
  • Rodríguez-Rodríguez, Eloy
  • Alarcón-Martín, Emilio
  • Orellana, Adelina
  • Pastor, Pau
  • Pérez-Tur, Jordi
  • Pinol-Ripoll, Gerard
  • López de Munain, Adolfo
  • García-Alberca, José María
  • Royo, José Luis
  • Bullido, María Jesús
  • Álvarez, Victoria
  • Real, Luis Miguel
  • Corbatón Anchuelo, Arturo
  • Gómez-Garre, Dulcenombre
  • Martínez Larrad, María Teresa
  • Franco-Macias, Emilio
  • Mir, Pablo
  • Medina, Miguel
  • Sánchez-Valle, Raquel
  • Icardo, Oriol
  • Dols-Sáez, María Eugenia
  • Carracedo, Ángel
  • Tárraga, Lluís
  • Alegret, Montse
  • Valero, Sergi
  • Marquie, Marta
  • Boada, Mercè
  • Juan, Pascual
  • Sánchez Cavazos, José Enrique
  • Cabrera, Alfredo
  • Cano, Amanda
  • Ruiz, Agustín
preprint 42 páginas, 6 figuras, 2 tablas, Background: Alzheimer's disease (AD) has a high heritable component characteristic of complex diseases, yet many of the genetic risk factors remain unknown. We combined genome-wide association studies (GWAS) on amyloid endophenotypes measured in cerebrospinal fluid (CSF) and positron emission tomography (PET) as surrogates of amyloid pathology, which may be helpful to understand the underlying biology of the disease. Methods: We performed a meta-analysis of GWAS of CSF Aβ42 and PET measures combining six independent cohorts (n=2,076). Due to the opposite effect direction of Aβ phenotypes in CSF and PET measures, only genetic signals in the opposite direction were considered for analysis (n=376,599). Polygenic risk scores (PRS) were calculated and evaluated for AD status and amyloid endophenotypes. We then searched the CSF proteome signature of brain amyloidosis using SOMAscan proteomic data (Ace cohort, n=1,008) and connected it with GWAS results of loci modulating amyloidosis. Finally, we compared our results with a large meta-analysis using publicly available datasets in CSF (n=13,409) and PET (n=13,116). This combined approach enabled the identification of overlapping genes and proteins associated with amyloid burden and the assessment of their biological significance using enrichment analyses. Results: After filtering the meta-GWAS, we observed genome-wide significance in the rs429358-APOE locus and nine suggestive hits were annotated. We replicated the APOE loci using the large CSF-PET meta-GWAS and identified multiple AD-associated genes as well as the novel GADL1 locus. Additionally, we found a significant association between the AD PRS and amyloid levels, whereas no significant association was found between any Aβ PRS with AD risk. CSF SOMAscan analysis identified 1,387 FDR-significant proteins associated with CSF Aβ42 levels. The overlap among GWAS loci and proteins associated with amyloid burden was very poor (n=35). The enrichment analysis of overlapping hits strongly suggested several signalling pathways connecting amyloidosis with the anchored component of the plasma membrane, synapse physiology and mental disorders that were replicated in the large CSF-PET meta-analysis. Conclusions: The strategy of combining CSF and PET amyloid endophenotypes GWAS with CSF proteome analyses might be effective for identifying signals associated with the AD pathological process and elucidate causative molecular mechanisms behind the amyloid mobilization in AD., The Genome Research @ Ace Alzheimer Center Barcelona project (GR@ACE) is supported by Grifols SA, Fundación bancaria 'La Caixa', Ace Alzheimer Center Barcelona and CIBERNED. Ace Alzheimer Center Barcelona is one of the participating centers of the Dementia Genetics Spanish Consortium (DEGESCO). The FACEHBI study is supported by funds from Ace Alzheimer Center Barcelona, Grifols, Life Molecular Imaging, Araclon Biotech, Alkahest, Laboratorio de análisis Echevarne and IrsiCaixa. Authors acknowledge the support of the Spanish Ministry of Science and Innovation, Proyectos de Generación de Conocimiento grants PID2021-122473OA-I00, PID2021-123462OB-I00 and PID2019-106625RB-I00. ISCIII, Acción Estratégica en Salud, integrated in the Spanish National R+D+I Plan and financed by ISCIII Subdirección General de Evaluación and the Fondo Europeo de Desarrollo Regional (FEDER 'Una manera de hacer Europa') grants PI13/02434, PI16/01861, PI17/01474, PI19/00335, PI19/01240, PI19/01301, PI22/01403, PI22/00258 and the ISCIII national grant PMP22/00022, funded by the European Union (NextGenerationEU). The support of CIBERNED (ISCIII) under the grants CB06/05/2004 and CB18/05/00010. The support from the ADAPTED and MOPEAD projects, European Union/EFPIA Innovative Medicines Initiative Joint (grant numbers 115975 and 115985, respectively); from PREADAPT project, Joint Program for Neurodegenerative Diseases (JPND) grant AC19/00097; from HARPONE project, Agency for Innovation and Entrepreneurship (VLAIO) grant PR067/21 and Janssen. DESCARTES project is funded by German Research Foundation (DFG). Additionally, IdR is supported by the Instituto de Salud Carlos III (ISCIII) under grant FI20/00215. PGG is supported by CIBERNED employment plan (CNV-304-PRF-866). ACF received support from the ISCIII under the grant Sara Borrell (CD22/00125). JEC received support from National Institute of Health award P30AG066546., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Linking genomic and proteomic signatures to brain amyloid burden: insights from GR@ACE/DEGESCO

  • Puerta, Raquel
  • Pérez-Tur, Jordi
  • Bullido, María Jesús
  • Real, Luis Miguel
  • Mir, Pablo
  • Ruiz, Agustín
  • Alzheimer’s Disease Neuroimaging Initiative
27 páginas, 7 figuras, 3 tablas, Alzheimer's disease (AD) is a complex disease with a strong genetic component, yet many genetic risk factors remain unknown. We combined genome-wide association studies (GWAS) on amyloid endophenotypes measured in cerebrospinal fluid (CSF) and positron emission tomography (PET) as surrogates of amyloid pathology, which may provide insights into the underlying biology of the disease. We performed a meta-GWAS of CSF Aβ42 and PET measures combining six independent cohorts (n = 2,076). Given the opposite beta direction of Aβ phenotypes in CSF and PET measures, only genetic signals showing opposite directions were considered for analysis (n = 376,599). We explored the amyloidosis signature in the CSF proteome using SOMAscan proteomics (ACE cohort, n = 1,008), connected it with GWAS loci modulating amyloidosis and performed an enrichment analysis of overlapping hits. Finally, we compared our results with a large meta-analysis using publicly available datasets in CSF (n = 13,409) and PET (n = 13,116). After filtering the meta-GWAS, we observed genome-wide significance in the rs429358-APOE locus and annotated nine suggestive hits. We replicated the APOE loci using the large CSF-PET meta-GWAS, identifying multiple AD-associated genes including the novel GADL1 locus. Additionally, we found 1,387 FDR-significant SOMAscan proteins associated with CSF Aβ42 levels. The overlap among GWAS loci and proteins associated with amyloid burden was minimal (n = 35). The enrichment analysis revealed mechanisms connecting amyloidosis with the plasma membrane's anchored component, synapse physiology and mental disorders that were replicated in the large CSF-PET meta-analysis. Combining CSF and PET amyloid GWAS with CSF proteome analyses may effectively elucidate causative molecular mechanisms behind amyloid mobilization and AD physiopathology., The Genome Research @ Ace Alzheimer Center Barcelona project (GR@ACE) is supported by Grifols SA, Fundación bancaria ‘La Caixa’, Ace Alzheimer Center Barcelona and CIBERNED. Ace Alzheimer Center Barcelona is one of the participating centers of the Dementia Genetics Spanish Consortium (DEGESCO). The FACEHBI study is supported by funds from Ace Alzheimer Center Barcelona, Grifols, Life Molecular Imaging, Araclon Biotech, Alkahest, Laboratorio de análisis Echevarne and IrsiCaixa. Authors acknowledge the support of the Spanish Ministry of Science and Innovation, Proyectos de Generación de Conocimiento grants PID2021-122473OA-I00, PID2021-123462OB-I00 and PID2019-106625RB-I00. ISCIII, Acción Estratégica en Salud, integrated in the Spanish National R + D + I Plan and financed by ISCIII Subdirección General de Evaluación and the Fondo Europeo de Desarrollo Regional (FEDER “Una manera de hacer Europa") grants PI13/02434, PI16/01861, PI17/01474, PI19/00335, PI19/01240, PI19/01301, PI22/01403, PI22/00258 and the ISCIII national grant PMP22/00022, funded by the European Union (NextGenerationEU). The support of CIBERNED (ISCIII) under the grants CB06/05/2004 and CB18/05/00010. The support from the ADAPTED and MOPEAD projects, European Union/EFPIA Innovative Medicines Initiative Joint (grant numbers 115975 and 115985, respectively); from PREADAPT project, Joint Program for Neurodegenerative Diseases (JPND) grant Nº AC19/00097; from HARPONE project, Agency for Innovation and Entrepreneurship (VLAIO) grant Nº PR067/21 and Janssen. DESCARTES project is funded by German Research Foundation (DFG). Additionally, AR is also supported by STAR Award. University of Texas System. Tx, United States, The South Texas ADRC. National Institute of Aging. National Institutes of Heath. USA. (P30AG066546) and the Keith M. Orme and Pat Vigeon Orme Endowed Chair in Alzheimer’s and Neurodegenerative Diseases. IdR is supported by the Instituto de Salud Carlos III (ISCIII) under grant FI20/00215. PGG is supported by CIBERNED employment plan (CNV-304-PRF-866). ACF received support from the ISCIII under the grant Sara Borrell (CD22/00125). JEC received support from National Institute of Health award P30AG066546., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

A Spanish-Portuguese GWAS of progressive supranuclear palsy reveals a novel risk locus in NFASC

  • García-González, Pablo
  • Díaz Belloso, Rafael
  • Munoz-Delgado, Laura
  • Buiza Rueda, Dolores
  • Gómez-Garre, Pilar
  • Pérez-Tur, Jordi
  • Real, Luis M.
  • Bullido, María Jesús
  • Ruiz, Agustín
18 páginas, 2 figuras, Progressive supranuclear palsy (PSP) is a rare 4-repeat tauopathy that causes behavioural, movement and cognitive abnormalities. We genotyped all available clinical and histopathological PSP cases in Spain and Portugal (N = 522), and conducted the largest PSP GWAS of the Iberian population to date. Genetic burden analysis revealed reduced diagnostic specificity in clinically diagnosed atypical PSP cases-when applying the 2017 MDS criteria-compared to Richardson's syndrome cases. We independently replicated eight PSP risk variants in seven known loci (MAPT, MOBP, EIF2AK3, STX6, SLCO1A2, DUSP10 and APOE), and identified a novel locus in NFASC/CNTN2 (rs12744678 C: OR[95%CI] = 0.83[0.78-0.89]; p = 4.15·10-08) after meta-analysis with a newly available Dutch cohort and publicly available summary statistics (3,099 PSP; 11,482 controls). Enrichment analysis and protein expression profiling highlighted oligodendrocyte function and myelination as likely contributors to PSP pathogenesis. Our findings broaden the genetic landscape of PSP and suggest potential therapeutic avenues focused on modulating neuron-oligodendrocyte interactions., This work was funded by CIBERNED (Centro Investigación Biomédica en Red Enfermedades Neurodegenerativas) 10th internal call for cooperative projects (Register number: 2019/09). Agustín Ruiz, Pascual Sanchez-Juan, Alberto Rábano, and Maria J. Bullido received funding from this convocatory. Pablo García-González received support by CIBERNED employment plan CNV-304-PRF-866. CIBERNED is integrated into ISCIII (Instituto de Salud Carlos III). Mercé Boada, Marta Marquié and Agustín Ruiz are also supported by national grants PI13/02434, PI16/01861, PI17/01474, PI19/01240, PI19/01301, PI19/00335 and PI22/011403, and CIBERNED grant 2019/08. The Genome Research @ Fundació ACE project (GR@ACE) is supported by Grifols SA, Fundación bancaria “La Caixa”, Fundació ACE, and CIBERNED. Acción Estratégica en Salud is integrated into the Spanish National R  +  D  +  I Plan and funded by ISCIII—Subdirección General de Evaluación and the Fondo Europeo de Desarrollo Regional (FEDER—“Una manera de hacer Europa”). Agustín Ruiz is supported by ISCIII national grant PMP22/00022, funded by the European Union (NextGenerationEU). He is also supported by the STAR Award. University of Texas System. Tx, United States, The South Texas ADRC. National Institute of Aging. National Institutes of Health. USA. (P30AG066546), the Keith M. Orme and Pat Vigeon Orme Endowed Chair in Alzheimer’s and Neurodegenerative Diseases (2024-2025) and Patricia Ruth Frederick Distinguished Chair for Precision Therapeutics in Alzheimer’s and Neurodegenerative Diseases (2025-2028). The genotyping service to generate GR@ACE and PSP/DEGESCO GWAS data was carried out at CEGEN-PRB3-ISCIII; it is supported by grant PT17/0019, of the PE I + D + i 2013-2016, funded by ISCIII and ERDF”. Itziar de Rojas received support by a national grant from ISCIII FI20/00215. Amanda Cano acknowledges the support of the Spanish Ministry of Science, Innovation and Universities under the grant Juan de la Cierva (FJC2018-036012-I), the support of ISCIII under the grant Sara Borrell (CD22/00125), Spanish Ministry of Science and Innovation, Proyectos de Generación de Conocimiento grant PID2021-122473OA-I00, and Fundación ADEY under the program “Proyectos de Investigación en Salud 2023”. Fondo de Investigacion en Salud (Instituto Carlos III) (PI17/00096) in the frame of the European Regional Development Fund (ERDF) and to Fundacio ́ la Marato ́ de TV3 (PI043296 and 202009-10). This work was supported by the Spanish Ministry of Science and Innovation (RTC2019-007150-1), the Instituto de Salud Carlos III (ISCIII) and co-funded by the European Union (PI14/01823, PI16/01575, PI18/01898, PI19/01576, PI21/01875), the Consejería de Economía, Innovación, Ciencia y Empleo de la Junta de Andalucía (CVI-02526, CTS-7685, PY20_00896), and the Consejería de Salud y Bienestar Social de la Junta de Andalucía (PI-0471-2013, PE-0210-2018, PI-0459-2018, PE-0186-2019). Pilar Gómez-Garre was supported by the “Nicolás Monardes” program (C-0048-2017) from Andalusian Regional Ministry of Health. Laura Muñoz-Delgado was supported by the “Río Hortega” program [CM21/00051] from the Instituto de Salud Carlos III (ISCIII-FEDER). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Sven J. van der Lee was funded for this study by NWO (#733050512, PROMO-GENODE: a PROspective study of MOnoGEnic causes Of Dementia) a substantial donation by Edwin Bouw Fonds and Dioraphte. SvdL further received funding for the GeneMINDS consortium, which is powered by Health~Holland, Top Sector Life Sciences & Health. Sven J. van der Lee is a recipient of ABOARD, which is a public-private partnership receiving funding from ZonMW (#73305095007) and Health~Holland, Topsector Life Sciences & Health (PPP-allowance; #LSHM20106). More than 30 partners participate in ABOARD. ABOARD also receives funding from Edwin Bouw Fonds and Gieskes-Strijbisfonds. ABOARD also receives funding from de Hersenstichting, Edwin Bouw Fonds and Gieskes-Strijbisfonds. Array genotyping was performed in the context of EADB (European Alzheimer DNA biobank) funded by the JPco-fuND FP-829-029 (ZonMW projectnumber 733051061). This work has been supported by the Queen Sofia Foundation. Pascual Sánchez-Juan is supported by grants from ISCIII (PMP22/00022 and PI20/01011) and TED2021-131676B-100. Luis Miguel Real received support from “The absence of seroconversion after exposition to hepatitis C virus is not related to KIR-HLA genotype combinations” (GEHEP-012 study). Consejería de Salud de la Junta de Andalucía (grant number PI-0001/2017) and CIBERINFEC -Consorcio Centro de Investigación Biomédica en Red de Enfermedades Infecciosas- Instituto de Salud Carlos III, Ministerio de Ciencia e Innovación y Unión Europea (Spain) (NextGeneration EU) (grant number CB21/13/00118). Jose Luis Royo received support from Project 23.04.2021 from Santángela Foundation (Sevilla, Spain)., Peer reviewed
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Long runs of homozygosity are associated with Alzheimer's disease

  • Moreno-Grau, Sonia
  • Fernández, Maria Victoria|||0000-0002-9669-5147
  • De Rojas, Itziar|||0000-0002-2148-381X
  • García-González, Pablo|||0000-0003-0125-5403
  • Hernández, Isabel|||0000-0001-8119-393X
  • Farias, Fabiana|||0000-0002-5215-7304
  • Budde, John P.|||0000-0001-7778-7276
  • Quintela, Inés|||0000-0002-0239-7975
  • Madrid, Laura|||0000-0001-5851-3341
  • González-Pérez, Antonio
  • Montrreal Navarro, Laura|||0000-0002-0010-645X
  • Alarcón-Martín, Emilio|||0000-0002-0985-872X
  • Alegret, Montserrat|||0000-0002-8164-9500
  • Maroñas, Olalla
  • Pineda, Juan Antonio
  • Macías, Juan|||0000-0002-4778-790X
  • Marquié, Marta|||0000-0002-0660-0950
  • Valero, Sergi|||0000-0002-6599-948X
  • Benaque, Alba
  • Clarimón, Jordi|||0000-0002-6824-6942
  • Bullido, María J.|||0000-0002-6477-1117
  • García-Ribas, Guillermo
  • Pastor, Pau|||0000-0002-7493-8777
  • Sánchez-Juan, Pascual|||0000-0002-6081-8037
  • Alvarez, Victoria|||0000-0002-1916-2523
  • Piñol-Ripoll, Gerard
  • García-Alberca, Jose María|||0000-0003-2951-6644
  • Royo, José Luis
  • Franco-Macías, Emilio|||0000-0003-4186-1037
  • Mir, Pablo|||0000-0003-1656-302X
  • Calero, Miguel|||0000-0001-5366-3324
  • Medina, Miguel|||0000-0002-7016-5340
  • Rábano, Alberto|||0000-0001-9320-6566
  • Ávila, Jesús
  • Antúnez, Carmen
  • Real, Luis M.|||0000-0003-4932-7429
  • Orellana del Río, Adelina|||0000-0002-0204-1944
  • Carracedo, Ángel|||0000-0003-1085-8986
  • Sáez, María Eugenia|||0000-0001-9299-2534
  • Tárraga, Lluís|||0000-0002-8423-946X
  • Boada, Mercè|||0000-0003-2617-3009
  • Cruchaga, Carlos|||0000-0002-0276-2899
  • Ruiz Laza, Agustín|||0000-0003-2633-2495
Long runs of homozygosity (ROH) are contiguous stretches of homozygous genotypes, which are a footprint of inbreeding and recessive inheritance. The presence of recessive loci is suggested for Alzheimer's disease (AD); however, their search has been poorly assessed to date. To investigate homozygosity in AD, here we performed a fine-scale ROH analysis using 10 independent cohorts of European ancestry (11,919 AD cases and 9181 controls.) We detected an increase of homozygosity in AD cases compared to controls [ β (CI 95%) = 0.070 (0.037-0.104); P = 3.91 × 10 -5 ; β (CI95%) = 0.043 (0.009-0.076); P = 0.013]. ROHs increasing the risk of AD (OR.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Neuropsychiatric profiles and conversion to dementia in mild cognitive impairment, a latent class analysis

  • Roberto Herrero, Natalia|||0000-0002-5391-2711
  • Portella Moll, Maria J., 1975-|||0000-0002-2007-9516
  • Marquié, Marta|||0000-0002-0660-0950
  • Alegret, Montserrat|||0000-0002-8164-9500
  • Hernández, Isabel|||0000-0001-8119-393X
  • Mauleón, Ana|||0000-0002-4218-2127
  • Rosende-Roca, Maitée|||0000-0003-1778-8175
  • Abdelnour, Carla|||0000-0002-7636-9758
  • Esteban de Antonio, Ester|||0000-0003-1965-6010
  • Gil-Navarro, Silvia|||0000-0001-9921-9042
  • Tartari, Juan P.
  • Vargas, Liliana|||0000-0001-5685-5903
  • Espinosa, Ana|||0000-0001-7399-3267
  • Ortega Linares, Gemma|||0000-0002-7479-4072
  • Pérez-Cordón, Alba|||0000-0002-6028-0791
  • Sanabria, Ángela|||0000-0002-7501-9895
  • Orellana del Río, Adelina|||0000-0002-0204-1944
  • De Rojas, Itziar|||0000-0002-2148-381X
  • Moreno-Grau, Sonia
  • Montrreal Navarro, Laura|||0000-0002-0010-645X
  • Alarcón-Martín, Emilio|||0000-0002-0985-872X
  • Ruiz Laza, Agustín|||0000-0003-2633-2495
  • Tárraga, Lluís|||0000-0002-8423-946X
  • Boada, Mercè|||0000-0003-2617-3009
  • Valero, Sergi|||0000-0002-6599-948X
Neuropsychiatric symptoms (NPS) have been recently addressed as risk factors of conversion to Alzheimer's disease (AD) and other dementia types in patients diagnosed with Mild Cognitive Impairment (MCI). Our aim was to determine profiles based on the prominent NPS in MCI patients and to explore the predictive value of these profiles on conversion to specific types of dementia. A total of 2137 MCI patients monitored in a memory clinic were included in the study. Four NPS profiles emerged (classes), which were defined by preeminent symptoms: Irritability, Apathy, Anxiety/Depression and Asymptomatic. Irritability and Apathy were predictors of conversion to dementia (HR = 1.43 and 1.56, respectively). Anxiety/depression class showed no risk effect of conversion when compared to Asymptomatic class. Irritability class appeared as the most discriminant neuropsychiatric condition to identify non-AD converters (i.e., frontotemporal dementia, vascular dementia, Parkinson's disease and dementia with Lewy Bodies). The findings revealed that consistent subgroups of MCI patients could be identified among comorbid basal NPS. The preeminent NPS showed to behave differentially on conversion to dementia, beyond AD. Therefore, NPS should be used as early diagnosis facilitators, and should also guide clinicians to detect patients with different illness trajectories in the progression of MCI.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Common variants in Alzheimer's disease and risk stratification by polygenic risk scores

  • De Rojas, Itziar|||0000-0002-2148-381X
  • Moreno-Grau, Sonia
  • Tesi, Niccolo|||0000-0002-1413-5091
  • Grenier-Boley, Benjamin
  • Andrade, Victor|||0000-0003-0682-269X
  • Jansen, Iris E.|||0000-0003-1901-8131
  • Pedersen, Nancy L.|||0000-0001-8057-3543
  • Stringa, Najada|||0000-0001-6350-452X
  • Zettergren, Anna|||0000-0002-7182-8417
  • Hernández, Isabel|||0000-0001-8119-393X
  • Montrreal Navarro, Laura|||0000-0002-0010-645X
  • Antúnez, Carmen
  • Antonell, Anna|||0000-0002-3286-8459
  • Tankard, Rick M.|||0000-0002-8847-9401
  • Bis, Joshua C.|||0000-0002-3409-1110
  • Sims, Rebecca|||0000-0002-3885-1199
  • Bellenguez, Céline|||0000-0002-1240-7874
  • Quintela, Inés|||0000-0002-0239-7975
  • González-Perez, Antonio
  • Calero, Miguel|||0000-0001-5366-3324
  • Franco-Macías, Emilio|||0000-0003-4186-1037
  • Macías, Juan|||0000-0002-4778-790X
  • Blesa, Rafael|||0000-0003-4026-2884
  • Cervera Carles, Laura|||0000-0003-2286-200X
  • Mendez-Gonzalez, Manuel|||0000-0002-5218-0774
  • Frank García, Ana
  • Royo, Jose Luís
  • Moreno, Fermin|||0000-0001-5200-3164
  • Huerto Vilas, Raquel
  • Baquero, Miquel|||0000-0002-6861-1831
  • Diez-Fairen, Monica|||0000-0003-1882-0309
  • Lage, Carmen|||0000-0003-1703-121X
  • García-Madrona, Sebastián
  • García-González, Pablo|||0000-0003-0125-5403
  • Alarcón-Martín, Emilio|||0000-0002-0985-872X
  • Valero, Sergi|||0000-0002-6599-948X
  • Sotolongo Grau, Oscar|||0000-0002-9679-0670
  • Ullgren, Abbe
  • Naj, Adam C.|||0000-0002-9621-2942
  • Lemstra, Afina W.|||0000-0002-8933-3260
  • Benaque, Alba
  • Pérez-Cordón, Alba|||0000-0002-6028-0791
  • Benussi, Alberto|||0000-0002-8703-6940
  • Rábano, Alberto|||0000-0001-9320-6566
  • Padovani, Alessandro|||0000-0002-0119-3639
  • Squassina, Alessio|||0000-0001-7415-7607
  • de Mendonça, Alexandre|||0000-0002-0488-1453
  • Arias Pastor, Alfonso
  • Kok, Almar A. L.
  • Meggy, Alun
  • Pastor, Ana Belén|||0000-0001-9637-4688
  • Espinosa, Ana|||0000-0001-7399-3267
  • Corma Gómez, Anaïs|||0000-0002-1078-0237
  • Martín Montes, Angel|||0000-0002-1694-786X
  • Sanabria, Ángela|||0000-0002-7501-9895
  • DeStefano, Anita L.|||0000-0002-9335-2819
  • Schneider, Anja|||0000-0001-9540-8700
  • Haapasalo, Annakaisa|||0000-0003-0959-2957
  • Kinhult Ståhlbom, Anne
  • Tybjærg-Hansen, Anne
  • Hartmann, Annette M.
  • Spottke, Annika
  • Corbatón-Anchuelo, Arturo
  • Rongve, Arvid|||0000-0002-0476-4134
  • Borroni, Barbara|||0000-0001-9340-9814
  • Arosio, Beatrice|||0000-0002-0615-3580
  • Nacmias, Benedetta|||0000-0001-9338-9040
  • Nordestgaard, Børge G.|||0000-0002-1954-7220
  • Kunkle, Brian W.
  • Charbonnier, Camille|||0000-0003-1172-0196
  • Abdelnour, Carla|||0000-0002-7636-9758
  • Masullo, Carlo|||0000-0001-7798-3410
  • Martínez Rodríguez, Carmen
  • Muñoz-Fernandez, Carmen
  • Dufouil, Carole|||0000-0003-2442-4476
  • Graff, Caroline|||0000-0002-9949-2951
  • Ferreira, Catarina B.
  • Chillotti, Caterina
  • Reynolds, Chandra A.|||0000-0001-6502-7173
  • Fenoglio, Chiara|||0000-0001-6332-4721
  • Van Broeckhoven, Christine|||0000-0003-0183-7665
  • Clark, Christopher|||0000-0001-7210-7702
  • Pisanu, Claudia|||0000-0002-9151-4319
  • Satizabal, Claudia L.|||0000-0002-1115-4430
  • Holmes, Clive
  • Buiza-Rueda, Dolores|||0000-0002-3504-9299
  • Aarsland, Dag|||0000-0001-6314-216X
  • Rujescu, Dan|||0000-0002-1432-313X
  • Alcolea, Daniel|||0000-0002-3819-3245
  • Galimberti, Daniela|||0000-0002-9284-5953
  • Wallon, David|||0000-0002-2634-7198
  • Seripa, Davide|||0000-0001-7331-0470
  • Grünblatt, Edna|||0000-0001-8505-7265
  • Dardiotis, Efthimios|||0000-0003-2957-641X
  • Düzel, Emrah
  • Scarpini, Elio|||0000-0002-6395-2119
  • Conti, Elisa
  • Rubino, Elisa|||0000-0002-7553-7553
  • Gelpi, Ellen|||0000-0003-2948-4187
  • Rodríguez-Rodríguez, Eloy|||0000-0001-7742-677X
  • Duron, Emmanuelle
  • Boerwinkle, Eric|||0000-0001-8813-0544
  • Ferri, Evelyn
  • Tagliavini, Fabrizio|||0000-0003-1039-7315
  • Küçükali, Fahri
  • Pasquier, Florence|||0000-0001-9880-9788
  • Sánchez García, Florentino
  • Mangialasche, Francesca
  • Jessen, Frank
  • Nicolas, Gael|||0000-0001-9391-7800
  • Selbæk, Geir|||0000-0001-6511-8219
  • Ortega Linares, Gemma|||0000-0002-7479-4072
  • Chene, Geneviève|||0000-0002-8368-6460
  • Hadjigeorgiou, Georgios
  • Rossi, Giacomina|||0000-0001-6680-2725
  • Spalletta, Gianfranco|||0000-0002-7432-4249
  • Giaccone, Giorgio|||0000-0002-4803-0802
  • Grande, Giulia
  • Binetti, Giuliano|||0000-0003-2759-5844
  • Papenberg, Goran
  • Hampel, Harald
  • Bailly, Henri
  • Zetterberg, Henrik|||0000-0003-3930-4354
  • Soininen, Hilkka|||0000-0002-2785-9937
  • Karlsson, Ida K.
  • Alvarez, Ignacio|||0000-0002-8537-3935
  • Appollonio, Ildebrando
  • Giegling, Ina
  • Skoog, Ingmar
  • Saltvedt, Ingvild|||0000-0002-7897-9808
  • Rainero, Innocenzo|||0000-0001-6074-9628
  • Rosas Allende, Irene
  • Hort, Jakub|||0000-0002-1080-3726
  • Diehl-Schmid, Janine|||0000-0002-7745-1382
  • Van Dongen, Jasper|||0000-0001-5599-0046
  • Vidal, Jean-Sébastien|||0000-0001-6770-0720
  • Lehtisalo, Jenni
  • Wiltfang, Jens
  • Thomassen, Jesper Qvist|||0000-0003-3484-9531
  • Kornhuber, Johannes|||0000-0002-8096-3987
  • Haines, Jonathan L.|||0000-0002-4351-4728
  • Vogelgsang, Jonathan|||0000-0001-9326-8193
  • Pineda, Juan A.|||0000-0002-3751-0296
  • Fortea, Juan|||0000-0002-1340-638X
  • Popp, Julius|||0000-0002-0068-0312
  • Deckert, Jürgen|||0000-0003-1008-4650
  • Buerger, Katharina
  • Morgan, Kevin|||0000-0002-8217-2396
  • Fließbach, Klaus
  • Sleegers, Kristel|||0000-0002-0283-2332
  • Molina-Porcel, Laura|||0000-0003-4068-8578
  • Kilander, Lena
  • Weinhold, Leonie
  • Farrer, Lindsay A.|||0000-0001-5533-4225
  • Wang, Li-San
  • Kleineidam, Luca
  • Farotti, Lucia
  • Parnetti, Lucilla|||0000-0001-5722-3967
  • Tremolizzo, Lucio|||0000-0003-0473-6560
  • Hausner, Lucrezia|||0000-0001-9009-2356
  • Benussi, Luisa|||0000-0003-2836-8141
  • Froelich, Lutz|||0000-0003-1494-0813
  • Ikram, M. Arfan|||0000-0003-0372-8585
  • Deniz Naranjo, M. Cándida
  • Tsolaki, Magda|||0000-0002-2072-8010
  • Rosende-Roca, Maitée|||0000-0003-1778-8175
  • Löwenmark, Malin
  • Hulsman, Marc|||0000-0002-9889-3606
  • Spallazzi, Marco|||0000-0002-8091-2063
  • Pericak-Vance, Margaret A.|||0000-0001-7283-8804
  • Esiri, Margaret
  • Bernal Sánchez-Arjona, María
  • Dalmasso, Maria Carolina|||0000-0002-4901-9955
  • Martínez-Larrad, María Teresa
  • Arcaro, Marina|||0000-0002-3821-0682
  • Nöthen, Markus M.|||0000-0002-8770-2464
  • Fernández-Fuertes, Marta
  • Dichgans, Martin|||0000-0002-0654-387X
  • Ingelsson, Martin|||0000-0001-5466-8370
  • Herrmann, Martin J.|||0000-0001-9970-2122
  • Scherer, Martin
  • Vyhnalek, Martin
  • Kosmidis, Mary H.
  • Yannakoulia, Mary
  • Schmid, Matthias
  • Ewers, Michael|||0000-0001-5231-1714
  • Heneka, Michael|||0000-0003-4996-1630
  • Wagner, Michael
  • Scamosci, Michela
  • Kivipelto, Miia
  • Hiltunen, Mikko|||0000-0003-3566-4096
  • Zulaica, Miren
  • Alegret, Montserrat|||0000-0002-8164-9500
  • Fornage, Myriam|||0000-0003-0677-8158
  • Roberto Herrero, Natalia|||0000-0002-5391-2711
  • van Schoor, Natasja M.
  • Seidu, Nazib M.
  • Banaj, Nerisa|||0000-0002-6317-8549
  • Armstrong, Nicola|||0000-0002-4477-293X
  • Scarmeas, Nikolaos|||0000-0001-6453-8908
  • Scherbaum, Norbert|||0000-0003-1759-6990
  • Goldhardt, Oliver
  • Hanon, Olivier|||0000-0002-4697-122X
  • Peters, Oliver|||0000-0003-0568-2998
  • Skrobot, Olivia Anna
  • Quenez, Olivier|||0000-0002-8273-8505
  • Lerch, Ondrej
  • Bossù, Paola|||0000-0002-1432-0078
  • Caffarra, Paolo
  • Dionigi Rossi, Paolo
  • Sakka, Paraskevi
  • Hoffmann, Per|||0000-0002-6573-983X
  • Holmans, Peter|||0000-0003-0870-9412
  • Fischer, Peter
  • Riederer, Peter
  • Yang, Qiong|||0000-0002-3658-1375
  • Marshall, Rachel
  • Kalaria, Rajesh N.
  • Mayeux, Richard|||0000-0001-6519-9696
  • Vandenberghe, Rik|||0000-0001-6237-2502
  • Cecchetti, Roberta
  • Ghidoni, Roberta|||0000-0002-7691-1957
  • Frikke-Schmidt, Ruth|||0000-0003-4084-5027
  • Sorbi, Sandro|||0000-0002-0380-6670
  • Hägg, Sara|||0000-0002-2452-1500
  • Engelborghs, Sebastiaan|||0000-0003-0304-9785
  • Helisalmi, Seppo
  • Botne Sando, Sigrid
  • Kern, Silke
  • Archetti, Silvana
  • Boschi, Silvia|||0000-0003-1610-1917
  • Fostinelli, Silvia
  • Gil-Navarro, Silvia|||0000-0001-9921-9042
  • Mendoza, Silvia
  • Mead, Simon|||0000-0002-4326-1468
  • Ciccone, Simona
  • Djurovic, Srdjan|||0000-0002-8140-8061
  • Heilmann-Heimbach, Stefanie|||0000-0003-1057-465X
  • Riedel-Heller, Steffi|||0000-0003-4321-6090
  • Kuulasmaa, Teemu|||0000-0002-1795-7314
  • del Ser, Teodoro|||0000-0001-9806-7083
  • Lebouvier, Thibaud
  • Polak, Thomas
  • Ngandu, Tiia
  • Grimmer, Timo
  • Bessi, Valentina|||0000-0002-6176-3584
  • Escott-Price, Valentina|||0000-0003-1784-5483
  • Giedraitis, Vilmantas|||0000-0003-3423-2021
  • Deramecourt, Vincent
  • Maier, Wolfgang
  • Jian, Xueqiu
  • Pijnenburg, Yolande|||0000-0003-2464-1905
  • Kehoe, Patrick|||0000-0002-7542-1139
  • García-Ribas, Guillermo
  • Sánchez-Juan, Pascual|||0000-0002-6081-8037
  • Pastor, Pau|||0000-0002-7493-8777
  • Pérez-Tur, Jordi|||0000-0002-9111-1712
  • Piñol-Ripoll, Gerard
  • Lopez de Munain, Adolfo|||0000-0002-9509-4032
  • García-Alberca, Jose María|||0000-0003-2951-6644
  • Bullido, María J.|||0000-0002-6477-1117
  • Alvarez, Victoria|||0000-0002-1916-2523
  • Lleó, Alberto|||0000-0002-2568-5478
  • Real, Luis M.|||0000-0003-4932-7429
  • Mir, Pablo|||0000-0003-1656-302X
  • Medina, Miguel|||0000-0002-7016-5340
  • Scheltens, Philip|||0000-0002-1046-6408
  • Holstege, Henne|||0000-0002-7688-3087
  • Marquié, Marta|||0000-0002-0660-0950
  • Sáez, María Eugenia|||0000-0001-9299-2534
  • Carracedo, Ángel|||0000-0003-1085-8986
  • Amouyel, Philippe|||0000-0001-9088-234X
  • Schellenberg, Gerard D.
  • Williams, Julie|||0000-0002-4069-0259
  • Seshadri, Sudha|||0000-0001-6135-2622
  • van Duijn, Cornelia M.|||0000-0002-2374-9204
  • Mather, Karen A.|||0000-0003-4143-8941
  • Sánchez Valle, Raquel|||0000-0001-7750-896X
  • Serrano-Ríos, Manuel
  • Orellana del Río, Adelina|||0000-0002-0204-1944
  • Tárraga, Lluís|||0000-0002-8423-946X
  • Blennow, Kaj|||0000-0002-1890-4193
  • Huisman, Martijn A.
  • Andreassen, Ole A.|||0000-0002-4461-3568
  • Posthuma, Danielle|||0000-0001-7582-2365
  • Clarimón, Jordi|||0000-0002-6824-6942
  • Boada, Mercè|||0000-0003-2617-3009
  • van der Flier, Wiesje M.|||0000-0001-8766-6224
  • Ramirez, Alfredo|||0000-0003-4991-763X
  • Lambert, Jean-Charles|||0000-0003-0829-7817
  • van der Lee, Sven J.|||0000-0003-1606-8643
  • Ruiz Laza, Agustín|||0000-0003-2633-2495
Genetic discoveries of Alzheimer's disease are the drivers of our understanding, and together with polygenetic risk stratification can contribute towards planning of feasible and efficient preventive and curative clinical trials. We first perform a large genetic association study by merging all available case-control datasets and by-proxy study results (discovery n = 409,435 and validation size n = 58,190). Here, we add six variants associated with Alzheimer's disease risk (near APP, CHRNE, PRKD3/NDUFAF7, PLCG2 and two exonic variants in the SHARPIN gene). Assessment of the polygenic risk score and stratifying by APOE reveal a 4 to 5.5 years difference in median age at onset of Alzheimer's disease patients in APOE ɛ4 carriers. Because of this study, the underlying mechanisms of APP can be studied to refine the amyloid cascade and the polygenic risk score provides a tool to select individuals at high risk of Alzheimer's disease. Known genetic loci account for only a fraction of the genetic contribution to Alzheimer's disease. Here, the authors have performed a large genome-wide meta-analysis comprising 409,435 individuals to discover 6 new loci and demonstrate the efficacy of an Alzheimer's disease polygenic risk score.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Neuropsychiatric Profile as a Predictor of Cognitive Decline in Mild Cognitive Impairment

  • Roberto Herrero, Natalia|||0000-0002-5391-2711
  • Portella Moll, Maria J., 1975-|||0000-0002-2007-9516
  • Marquié, Marta|||0000-0002-0660-0950
  • Alegret, Montserrat|||0000-0002-8164-9500
  • Hernández, Isabel|||0000-0001-8119-393X
  • Mauleón, Ana|||0000-0002-4218-2127
  • Rosende-Roca, Maitée|||0000-0003-1778-8175
  • Abdelnour, Carla|||0000-0002-7636-9758
  • Esteban de Antonio, Ester|||0000-0003-1965-6010
  • Tartari, Juan P.
  • Vargas, Liliana|||0000-0001-5685-5903
  • López-Cuevas, Rogelio
  • Bojaryn, Urszula
  • Espinosa, Ana|||0000-0001-7399-3267
  • Ortega Linares, Gemma|||0000-0002-7479-4072
  • Pérez-Cordón, Alba|||0000-0002-6028-0791
  • Sanabria, Ángela|||0000-0002-7501-9895
  • Orellana del Río, Adelina|||0000-0002-0204-1944
  • De Rojas, Itziar|||0000-0002-2148-381X
  • Moreno-Grau, Sonia
  • Montrreal Navarro, Laura|||0000-0002-0010-645X
  • Alarcón-Martín, Emilio|||0000-0002-0985-872X
  • Ruiz Laza, Agustín|||0000-0003-2633-2495
  • Tárraga, Lluís|||0000-0002-8423-946X
  • Boada, Mercè|||0000-0003-2617-3009
  • Valero, Sergi|||0000-0002-6599-948X
Introduction: Mild cognitive impairment is often associated with affective and other neuropsychiatric symptoms (NPS). This co-occurrence might have a relevant impact on disease progression, from MCI to dementia. Objective: The aim of this study was to explore the trajectories of cognitive decline in an MCI sample from a memory clinic, taking into consideration a perspective of isolated cognitive functions and based on NPS clusters, accounting for the different comorbid symptoms collected at their baseline visit. Methods: A total of 2,137 MCI patients were monitored over a 2.4-year period. Four clusters of NPS (i.e., Irritability, Apathy, Anxiety/Depression and Asymptomatic) were used to run linear mixed models to explore the interaction of cluster with time on cognitive trajectories using a comprehensive neuropsychological battery (NBACE) administered at baseline and at the three subsequent follow-ups. Results: A significant interaction between cluster and time in cognitive decline was found when verbal learning and cued-recall were explored (p = 0.002 for both memory functions). For verbal learning, the Irritability cluster had the largest effect size (0.69), whereas the Asymptomatic cluster showed the smallest effect size (0.22). For cued-recall, the Irritability cluster had the largest effect size among groups (0.64), and Anxiety/Depression had the smallest effect size (0.21). Conclusions: In MCI patients, the Irritability and Apathy NPS clusters shared similar patterns of worsening in memory functioning, which could point to these NPS as risk factors of a faster cognitive decline, acting as early prognostic markers and helping in the diagnostic process.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Macular vessel density in the superficial plexus is not associated to cerebrospinal fluid core biomarkers for Alzheimer's disease in individuals with mild cognitive impairment, The NORFACE cohort

  • Marquié, Marta|||0000-0002-0660-0950
  • García-Sánchez, Ainhoa
  • Alarcón-Martín, Emilio|||0000-0002-0985-872X
  • Martínez, Joan|||0000-0001-7962-709X
  • Castilla Marti, Miguel|||0000-0003-1886-3536
  • Castilla-Martí, Luis|||0000-0002-7239-5289
  • Orellana del Río, Adelina|||0000-0002-0204-1944
  • Montrreal Navarro, Laura|||0000-0002-0010-645X
  • De Rojas, Itziar|||0000-0002-2148-381X
  • García-González, Pablo|||0000-0003-0125-5403
  • Puerta, Raquel|||0000-0002-1191-5893
  • Olivé Roig, Clàudia|||0000-0002-9438-5639
  • Cano, Amanda|||0000-0001-9567-4283
  • Hernández, Isabel|||0000-0001-8119-393X
  • Rosende-Roca, Maitée|||0000-0003-1778-8175
  • Vargas, Liliana|||0000-0001-5685-5903
  • Tartari, Juan Pablo
  • Esteban de Antonio, Ester|||0000-0003-1965-6010
  • Bojaryn, Urszula
  • Ricciardi, Mario
  • Ariton, Diana María|||0000-0002-6035-5466
  • Pytel, Vanesa
  • Alegret, Montserrat|||0000-0002-8164-9500
  • Ortega Linares, Gemma|||0000-0002-7479-4072
  • Espinosa, Ana|||0000-0001-7399-3267
  • Pérez-Cordón, Alba|||0000-0002-6028-0791
  • Sanabria, Ángela|||0000-0002-7501-9895
  • Muñoz, Nathalia
  • Lleonart, Núria
  • Aguilera, Núria
  • Tárraga, Lluís|||0000-0002-8423-946X
  • Valero, Sergi|||0000-0002-6599-948X
  • Ruiz Laza, Agustín|||0000-0003-2633-2495
  • Boada, Mercè|||0000-0003-2617-3009
Optical coherence tomography angiography (OCT-A) is a novel method in the dementia field that allows the detection of retinal vascular changes. The comparison of OCT-A measures with established Alzheimer's disease (AD)-related biomarkers is essential to validate the former as a marker of cerebrovascular impairment in the AD continuum. We aimed to investigate the association of macular vessel density (VD) in the superficial plexus quantified by OCT-A with the AT(N) classification based on cerebrospinal fluid (CSF) Aβ1-42, p181-tau and t-tau measurements in individuals with mild cognitive impairment (MCI). Clinical, demographic, ophthalmological, OCT-A and CSF core biomarkers for AD data from the Neuro-ophthalmology Research at Fundació ACE (NORFACE) project were analyzed. Differences in macular VD in four quadrants (superior, nasal, inferior, and temporal) among three AT(N) groups [Normal, Alzheimer and Suspected non-Alzheimer pathology (SNAP)] were assessed in a multivariate regression model, adjusted for age, APOE ε4 status, hypertension, diabetes mellitus, dyslipidemia, heart disease, chronic obstructive pulmonary disease and smoking habit, using the Normal AT(N) group as the reference category. The study cohort comprised 144 MCI participants: 66 Normal AT(N), 45 Alzheimer AT(N) and 33 SNAP AT(N). Regression analysis showed no significant association of the AT(N) groups with any of the regional macular VD measures (all, p.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Author Correction, Common variants in Alzheimer's disease and risk stratification by polygenic risk scores

  • De Rojas, Itziar|||0000-0002-2148-381X
  • Moreno-Grau, Sonia
  • Tesi, Niccolo|||0000-0002-1413-5091
  • Grenier-Boley, Benjamin
  • Andrade, Victor|||0000-0003-0682-269X
  • Jansen, Iris E.|||0000-0003-1901-8131
  • Pedersen, Nancy L.|||0000-0001-8057-3543
  • Stringa, Najada|||0000-0001-6350-452X
  • Zettergren, Anna|||0000-0002-7182-8417
  • Hernández, Isabel|||0000-0001-8119-393X
  • Montrreal Navarro, Laura|||0000-0002-0010-645X
  • Antúnez, Carmen
  • Antonell, Anna|||0000-0002-3286-8459
  • Tankard, Rick M.|||0000-0002-8847-9401
  • Bis, Joshua C.|||0000-0002-3409-1110
  • Sims, Rebecca|||0000-0002-3885-1199
  • Bellenguez, Céline|||0000-0002-1240-7874
  • Quintela, Inés|||0000-0002-0239-7975
  • González-Perez, Antonio
  • Calero, Miguel|||0000-0001-5366-3324
  • Franco-Macías, Emilio|||0000-0003-4186-1037
  • Macías, Juan|||0000-0002-4778-790X
  • Blesa, Rafael|||0000-0003-4026-2884
  • Cervera Carles, Laura|||0000-0003-2286-200X
  • Mendez-Gonzalez, Manuel|||0000-0002-5218-0774
  • Frank García, Ana
  • Royo, Jose Luís
  • Moreno, Fermin|||0000-0001-5200-3164
  • Huerto Vilas, Raquel
  • Baquero, Miquel|||0000-0002-6861-1831
  • Diez-Fairen, Monica|||0000-0003-1882-0309
  • Lage, Carmen|||0000-0003-1703-121X
  • García-Madrona, Sebastián
  • García-González, Pablo|||0000-0003-0125-5403
  • Alarcón-Martín, Emilio|||0000-0002-0985-872X
  • Valero, Sergi|||0000-0002-6599-948X
  • Sotolongo Grau, Oscar|||0000-0002-9679-0670
  • Ullgren, Abbe
  • Naj, Adam C.|||0000-0002-9621-2942
  • Lemstra, Afina W.|||0000-0002-8933-3260
  • Benaque, Alba
  • Pérez-Cordón, Alba|||0000-0002-6028-0791
  • Benussi, Alberto|||0000-0002-8703-6940
  • Rábano, Alberto|||0000-0001-9320-6566
  • Padovani, Alessandro|||0000-0002-0119-3639
  • Squassina, Alessio|||0000-0001-7415-7607
  • de Mendonça, Alexandre|||0000-0002-0488-1453
  • Arias Pastor, Alfonso
  • Kok, Almar A. L.
  • Meggy, Alun
  • Pastor, Ana Belén|||0000-0001-9637-4688
  • Espinosa, Ana|||0000-0001-7399-3267
  • Corma Gómez, Anaïs|||0000-0002-1078-0237
  • Martín Montes, Angel|||0000-0002-1694-786X
  • Sanabria, Ángela|||0000-0002-7501-9895
  • DeStefano, Anita L.|||0000-0002-9335-2819
  • Schneider, Anja|||0000-0001-9540-8700
  • Haapasalo, Annakaisa|||0000-0003-0959-2957
  • Kinhult Ståhlbom, Anne
  • Tybjærg-Hansen, Anne
  • Hartmann, Annette M.
  • Spottke, Annika
  • Corbatón-Anchuelo, Arturo
  • Rongve, Arvid|||0000-0002-0476-4134
  • Borroni, Barbara|||0000-0001-9340-9814
  • Arosio, Beatrice|||0000-0002-0615-3580
  • Nacmias, Benedetta|||0000-0001-9338-9040
  • Nordestgaard, Børge G.|||0000-0002-1954-7220
  • Kunkle, Brian W.
  • Charbonnier, Camille|||0000-0003-1172-0196
  • Abdelnour, Carla|||0000-0002-7636-9758
  • Masullo, Carlo|||0000-0001-7798-3410
  • Martínez Rodríguez, Carmen
  • Muñoz-Fernandez, Carmen
  • Dufouil, Carole|||0000-0003-2442-4476
  • Graff, Caroline|||0000-0002-9949-2951
  • Ferreira, Catarina B.
  • Chillotti, Caterina
  • Reynolds, Chandra A.|||0000-0001-6502-7173
  • Fenoglio, Chiara|||0000-0001-6332-4721
  • Van Broeckhoven, Christine|||0000-0003-0183-7665
  • Clark, Christopher|||0000-0001-7210-7702
  • Pisanu, Claudia|||0000-0002-9151-4319
  • Satizabal, Claudia L.|||0000-0002-1115-4430
  • Holmes, Clive
  • Buiza-Rueda, Dolores|||0000-0002-3504-9299
  • Aarsland, Dag|||0000-0001-6314-216X
  • Rujescu, Dan|||0000-0002-1432-313X
  • Alcolea, Daniel|||0000-0002-3819-3245
  • Galimberti, Daniela|||0000-0002-9284-5953
  • Wallon, David|||0000-0002-2634-7198
  • Seripa, Davide|||0000-0001-7331-0470
  • Grünblatt, Edna|||0000-0001-8505-7265
  • Dardiotis, Efthimios|||0000-0003-2957-641X
  • Düzel, Emrah
  • Scarpini, Elio|||0000-0002-6395-2119
  • Conti, Elisa
  • Rubino, Elisa|||0000-0002-7553-7553
  • Gelpi, Ellen|||0000-0003-2948-4187
  • Rodríguez-Rodríguez, Eloy|||0000-0001-7742-677X
  • Duron, Emmanuelle
  • Boerwinkle, Eric|||0000-0001-8813-0544
  • Ferri, Evelyn
  • Tagliavini, Fabrizio|||0000-0003-1039-7315
  • Küçükali, Fahri
  • Pasquier, Florence|||0000-0001-9880-9788
  • Sánchez García, Florentino
  • Mangialasche, Francesca
  • Jessen, Frank
  • Nicolas, Gael|||0000-0001-9391-7800
  • Selbæk, Geir|||0000-0001-6511-8219
  • Ortega, Gemma
  • Chene, Geneviève|||0000-0002-8368-6460
  • Hadjigeorgiou, Georgios
  • Rossi, Giacomina|||0000-0001-6680-2725
  • Spalletta, Gianfranco|||0000-0002-7432-4249
  • Giaccone, Giorgio|||0000-0002-4803-0802
  • Grande, Giulia
  • Binetti, Giuliano|||0000-0003-2759-5844
  • Papenberg, Goran
  • Hampel, Harald
  • Bailly, Henri
  • Zetterberg, Henrik|||0000-0003-3930-4354
  • Soininen, Hilkka|||0000-0002-2785-9937
  • Karlsson, Ida K.
  • Alvarez, Ignacio|||0000-0002-8537-3935
  • Appollonio, Ildebrando
  • Giegling, Ina
  • Skoog, Ingmar
  • Saltvedt, Ingvild|||0000-0002-7897-9808
  • Rainero, Innocenzo|||0000-0001-6074-9628
  • Rosas Allende, Irene
  • Hort, Jakub|||0000-0002-1080-3726
  • Diehl-Schmid, Janine|||0000-0002-7745-1382
  • Van Dongen, Jasper|||0000-0001-5599-0046
  • Vidal, Jean-Sébastien|||0000-0001-6770-0720
  • Lehtisalo, Jenni
  • Wiltfang, Jens
  • Thomassen, Jesper Qvist|||0000-0003-3484-9531
  • Kornhuber, Johannes|||0000-0002-8096-3987
  • Haines, Jonathan L.|||0000-0002-4351-4728
  • Vogelgsang, Jonathan|||0000-0001-9326-8193
  • Pineda, Juan A.|||0000-0002-3751-0296
  • Fortea, Juan|||0000-0002-1340-638X
  • Popp, Julius|||0000-0002-0068-0312
  • Deckert, Jürgen|||0000-0003-1008-4650
  • Buerger, Katharina
  • Morgan, Kevin|||0000-0002-8217-2396
  • Fließbach, Klaus
  • Sleegers, Kristel|||0000-0002-0283-2332
  • Molina-Porcel, Laura|||0000-0003-4068-8578
  • Kilander, Lena
  • Weinhold, Leonie
  • Farrer, Lindsay A.|||0000-0001-5533-4225
  • Wang, Li-San
  • Kleineidam, Luca
  • Farotti, Lucia
  • Parnetti, Lucilla|||0000-0001-5722-3967
  • Tremolizzo, Lucio|||0000-0003-0473-6560
  • Hausner, Lucrezia|||0000-0001-9009-2356
  • Benussi, Luisa|||0000-0003-2836-8141
  • Froelich, Lutz|||0000-0003-1494-0813
  • Ikram, M. Arfan|||0000-0003-0372-8585
  • Deniz Naranjo, M. Cándida
  • Tsolaki, Magda|||0000-0002-2072-8010
  • Rosende-Roca, Maitée|||0000-0003-1778-8175
  • Löwenmark, Malin
  • Hulsman, Marc|||0000-0002-9889-3606
  • Spallazzi, Marco|||0000-0002-8091-2063
  • Pericak-Vance, Margaret A.|||0000-0001-7283-8804
  • Esiri, Margaret
  • Bernal Sánchez-Arjona, María
  • Dalmasso, Maria Carolina|||0000-0002-4901-9955
  • Martínez-Larrad, María Teresa
  • Arcaro, Marina|||0000-0002-3821-0682
  • Nöthen, Markus M.|||0000-0002-8770-2464
  • Fernández-Fuertes, Marta
  • Dichgans, Martin|||0000-0002-0654-387X
  • Ingelsson, Martin|||0000-0001-5466-8370
  • Herrmann, Martin J.|||0000-0001-9970-2122
  • Scherer, Martin
  • Vyhnalek, Martin
  • Kosmidis, Mary H.
  • Yannakoulia, Mary
  • Schmid, Matthias
  • Ewers, Michael|||0000-0001-5231-1714
  • Heneka, Michael|||0000-0003-4996-1630
  • Wagner, Michael
  • Scamosci, Michela
  • Kivipelto, Miia
  • Hiltunen, Mikko|||0000-0003-3566-4096
  • Zulaica, Miren
  • Alegret, Montserrat|||0000-0002-8164-9500
  • Fornage, Myriam|||0000-0003-0677-8158
  • Roberto Herrero, Natalia|||0000-0002-5391-2711
  • van Schoor, Natasja M.
  • Seidu, Nazib M.
  • Banaj, Nerisa|||0000-0002-6317-8549
  • Armstrong, Nicola|||0000-0002-4477-293X
  • Scarmeas, Nikolaos|||0000-0001-6453-8908
  • Scherbaum, Norbert|||0000-0003-1759-6990
  • Goldhardt, Oliver
  • Hanon, Olivier|||0000-0002-4697-122X
  • Peters, Oliver|||0000-0003-0568-2998
  • Skrobot, Olivia Anna
  • Quenez, Olivier|||0000-0002-8273-8505
  • Lerch, Ondrej
  • Bossù, Paola|||0000-0002-1432-0078
  • Caffarra, Paolo
  • Dionigi Rossi, Paolo
  • Sakka, Paraskevi
  • Mecocci, Patrizia|||0000-0003-0729-5246
  • Hoffmann, Per|||0000-0002-6573-983X
  • Holmans, Peter|||0000-0003-0870-9412
  • Fischer, Peter
  • Riederer, Peter
  • Yang, Qiong|||0000-0002-3658-1375
  • Marshall, Rachel
  • Kalaria, Rajesh N.
  • Mayeux, Richard|||0000-0001-6519-9696
  • Vandenberghe, Rik|||0000-0001-6237-2502
  • Cecchetti, Roberta
  • Ghidoni, Roberta|||0000-0002-7691-1957
  • Frikke-Schmidt, Ruth|||0000-0003-4084-5027
  • Sorbi, Sandro|||0000-0002-0380-6670
  • Hägg, Sara|||0000-0002-2452-1500
  • Engelborghs, Sebastiaan|||0000-0003-0304-9785
  • Helisalmi, Seppo
  • Botne Sando, Sigrid
  • Kern, Silke
  • Archetti, Silvana
  • Boschi, Silvia|||0000-0003-1610-1917
  • Fostinelli, Silvia
  • Gil-Navarro, Silvia|||0000-0001-9921-9042
  • Mendoza, Silvia
  • Mead, Simon|||0000-0002-4326-1468
  • Ciccone, Simona
  • Djurovic, Srdjan|||0000-0002-8140-8061
  • Heilmann-Heimbach, Stefanie|||0000-0003-1057-465X
  • Riedel-Heller, Steffi|||0000-0003-4321-6090
  • Kuulasmaa, Teemu|||0000-0002-1795-7314
  • del Ser, Teodoro|||0000-0001-9806-7083
  • Lebouvier, Thibaud
  • Polak, Thomas
  • Ngandu, Tiia
  • Grimmer, Timo
  • Bessi, Valentina|||0000-0002-6176-3584
  • Escott-Price, Valentina|||0000-0003-1784-5483
  • Giedraitis, Vilmantas|||0000-0003-3423-2021
  • Deramecourt, Vincent
  • Maier, Wolfgang
  • Jian, Xueqiu
  • Pijnenburg, Yolande|||0000-0003-2464-1905
  • Kehoe, Patrick|||0000-0002-7542-1139
  • García-Ribas, Guillermo
  • Sánchez-Juan, Pascual|||0000-0002-6081-8037
  • Pastor, Pau|||0000-0002-7493-8777
  • Pérez-Tur, Jordi|||0000-0002-9111-1712
  • Piñol-Ripoll, Gerard
  • Lopez de Munain, Adolfo|||0000-0002-9509-4032
  • García-Alberca, Jose María|||0000-0003-2951-6644
  • Bullido, María J.|||0000-0002-6477-1117
  • Alvarez, Victoria|||0000-0002-1916-2523
  • Lleó, Alberto|||0000-0002-2568-5478
  • Real, Luis M.|||0000-0003-4932-7429
  • Mir, Pablo|||0000-0003-1656-302X
  • Medina, Miguel|||0000-0002-7016-5340
  • Scheltens, Philip|||0000-0002-1046-6408
  • Holstege, Henne|||0000-0002-7688-3087
  • Marquié, Marta|||0000-0002-0660-0950
  • Sáez, María Eugenia|||0000-0001-9299-2534
  • Carracedo, Ángel|||0000-0003-1085-8986
  • Amouyel, Philippe|||0000-0001-9088-234X
  • Schellenberg, Gerard D.
  • Williams, Julie|||0000-0002-4069-0259
  • Seshadri, Sudha|||0000-0001-6135-2622
  • van Duijn, Cornelia M.|||0000-0002-2374-9204
  • Mather, Karen A.|||0000-0003-4143-8941
  • Sánchez Valle, Raquel|||0000-0001-7750-896X
  • Serrano-Ríos, Manuel
  • Orellana del Río, Adelina|||0000-0002-0204-1944
  • Tárraga, Lluís|||0000-0002-8423-946X
  • Blennow, Kaj|||0000-0002-1890-4193
  • Huisman, Martijn A.
  • Andreassen, Ole A.|||0000-0002-4461-3568
  • Posthuma, Danielle|||0000-0001-7582-2365
  • Clarimón, Jordi|||0000-0002-6824-6942
  • Boada, Mercè|||0000-0003-2617-3009
  • van der Flier, Wiesje M.|||0000-0001-8766-6224
  • Ramirez, Alfredo|||0000-0003-4991-763X
  • Lambert, Jean-Charles|||0000-0003-0829-7817
  • van der Lee, Sven J.|||0000-0003-1606-8643
  • Ruiz Laza, Agustín|||0000-0003-2633-2495
Genetic discoveries of Alzheimer's disease are the drivers of our understanding, and together with polygenetic risk stratification can contribute towards planning of feasible and efficient preventive and curative clinical trials. We first perform a large genetic association study by merging all available case-control datasets and by-proxy study results (discovery n = 409,435 and validation size n = 58,190). Here, we add six variants associated with Alzheimer's disease risk (near APP, CHRNE, PRKD3/NDUFAF7, PLCG2 and two exonic variants in the SHARPIN gene). Assessment of the polygenic risk score and stratifying by APOE reveal a 4 to 5.5 years difference in median age at onset of Alzheimer's disease patients in APOE ɛ4 carriers. Because of this study, the underlying mechanisms of APP can be studied to refine the amyloid cascade and the polygenic risk score provides a tool to select individuals at high risk of Alzheimer's disease.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Genome-wide meta-analysis for Alzheimer's disease cerebrospinal fluid biomarkers

  • Jansen, Iris E.|||0000-0003-1901-8131
  • van der Lee, Sven J.|||0000-0003-1606-8643
  • Gomez-Fonseca, Duber
  • De Rojas, Itziar|||0000-0002-2148-381X
  • Dalmasso, Maria Carolina|||0000-0002-4901-9955
  • Grenier-Boley, Benjamin
  • Zettergren, Anna|||0000-0002-7182-8417
  • Mishra, Aniket|||0000-0002-8141-1543
  • Ali, Muhammad|||0000-0002-1399-6631
  • Andrade, Victor|||0000-0003-0682-269X
  • Bellenguez, Céline|||0000-0002-1240-7874
  • Kleineidam, Luca
  • Küçükali, Fahri
  • Sung, Ju Sung
  • Tesí, Niccolo
  • Vromen, Ellen|||0000-0001-7774-5500
  • Wightman, Douglas P.
  • Alcolea, Daniel|||0000-0002-3819-3245
  • Alegret, Montserrat|||0000-0002-8164-9500
  • Alvarez, Ignacio|||0000-0002-8537-3935
  • Amouyel, Philippe|||0000-0001-9088-234X
  • Athanasiu, Lavinia
  • Bahrami, Shahram
  • Bailly, Henri
  • Belbin, Olivia|||0000-0002-6109-6371
  • Bergh, Sverre|||0000-0001-9593-2967
  • Bertram, Lars|||0000-0002-0108-124X
  • Biessels, Geert Jan|||0000-0001-6862-2496
  • Blennow, Kaj|||0000-0002-1890-4193
  • Blesa, Rafael|||0000-0003-4026-2884
  • Boada, Mercè|||0000-0003-2617-3009
  • Boland, Anne|||0000-0001-8789-5676
  • Buerger, K.
  • Carracedo, Ángel|||0000-0003-1085-8986
  • Cervera Carles, Laura|||0000-0003-2286-200X
  • Chene, Geneviève|||0000-0002-8368-6460
  • Claassen, Jurgen|||0000-0002-1778-8151
  • Debette, Stéphanie|||0000-0001-8675-7968
  • Deleuze, Jean-Francois
  • De Deyn, Peter Paul|||0000-0002-2228-2964
  • Diehl-Schmid, Janine|||0000-0002-7745-1382
  • Djurovic, Srdjan|||0000-0002-8140-8061
  • Dols Icardo, Oriol|||0000-0003-2656-8748
  • Dufouil, Carole|||0000-0003-2442-4476
  • Duron, Emmanuelle
  • Düzel, Emrah
  • Fladby, Tormod|||0000-0002-9984-9797
  • Fortea, Juan|||0000-0002-1340-638X
  • Froelich, Lutz|||0000-0003-1494-0813
  • García-González, Pablo|||0000-0003-0125-5403
  • Garcia-Martinez, María
  • Giegling, Ina
  • Goldhardt, Oliver
  • Gobom, Johan|||0000-0001-6193-6193
  • Grimmer, Timo
  • Haapasalo, Annakaisa|||0000-0003-0959-2957
  • Hampel, Harald
  • Hanon, Olivier|||0000-0002-4697-122X
  • Hausner, Lucrezia|||0000-0001-9009-2356
  • Heilmann-Heimbach, Stefanie|||0000-0003-1057-465X
  • Helisalmi, Seppo
  • Heneka, Michael|||0000-0003-4996-1630
  • Hernández, Isabel|||0000-0001-8119-393X
  • Herukka, Sanna-Kaisa|||0000-0003-3308-8662
  • Holstege, Henne|||0000-0002-7688-3087
  • Jarholm, Jonas
  • Kern, Silke
  • Knapskog, Anne-Brita
  • Koivisto, A.M.
  • Kornhuber, Johannes|||0000-0002-8096-3987
  • Kuulasmaa, Teemu|||0000-0002-1795-7314
  • Lage, Carmen|||0000-0003-1703-121X
  • Laske, Christoph
  • Leinonen, Ville|||0000-0002-4282-4687
  • Lewczuk, Piotr|||0000-0002-8101-6535
  • Lleó, Alberto|||0000-0002-2568-5478
  • Lopez de Munain, Adolfo|||0000-0002-9509-4032
  • López-Garcia, Sara
  • Maier, Wolfgang
  • Marquié, Marta|||0000-0002-0660-0950
  • Mol, Merel O.|||0000-0003-2533-2530
  • Montrreal Navarro, Laura|||0000-0002-0010-645X
  • Moreno, Fermin|||0000-0001-5200-3164
  • Moreno-Grau, Sonia
  • Nicolas, Gael|||0000-0001-9391-7800
  • Nöthen, Markus M.|||0000-0002-8770-2464
  • Orellana del Río, Adelina|||0000-0002-0204-1944
  • Pålhaugen, Lene
  • Papma, Janne M.
  • Pasquier, Florence|||0000-0001-9880-9788
  • Perneczky, Robert|||0000-0003-1981-7435
  • Peters, Oliver|||0000-0003-0568-2998
  • Pijnenburg, Yolande A.L.
  • Popp, Julius|||0000-0002-0068-0312
  • Posthuma, Danielle|||0000-0001-7582-2365
  • Pozueta, Ana
  • Priller, Josef|||0000-0001-7596-0979
  • Puerta, Raquel|||0000-0002-1191-5893
  • Quintela, Inés|||0000-0002-0239-7975
  • Ramakers, Inez
  • Rodríguez-Rodríguez, Eloy|||0000-0001-7742-677X
  • Rujescu, Dan|||0000-0002-1432-313X
  • Saltvedt, Ingvild|||0000-0002-7897-9808
  • Sánchez-Juan, Pascual|||0000-0002-6081-8037
  • Scheltens, Philip|||0000-0002-1046-6408
  • Scherbaum, Norbert|||0000-0003-1759-6990
  • Schmid, Matthias
  • Schneider, Anja|||0000-0001-9540-8700
  • Selbæk, Geir|||0000-0001-6511-8219
  • Selnes, Per
  • Shadrin, Alexey
  • Skoog, Ingmar
  • Soininen, Hilkka|||0000-0002-2785-9937
  • Tárraga, Lluís|||0000-0002-8423-946X
  • Teipel, Stefan
  • Tijms, Betty M.|||0000-0002-2612-1797
  • Tsolaki, Magda|||0000-0002-2072-8010
  • Van Broeckhoven, Christine|||0000-0003-0183-7665
  • Van Dongen, Jasper|||0000-0001-5599-0046
  • van Swieten, John C.
  • Vandenberghe, Rik|||0000-0001-6237-2502
  • Vidal, Jean-Sébastien|||0000-0001-6770-0720
  • Visser, Pieter Jelle|||0000-0001-8008-9727
  • Vogelgsang, Jonathan|||0000-0001-9326-8193
  • Waern, Margda|||0000-0002-8330-6915
  • Wagner, Michael
  • Wiltfang, Jens W.
  • Wittens, Mandy M.J.
  • Zetterberg, Henrik|||0000-0003-3930-4354
  • Zulaica, Miren
  • van Duijn, Cornelia M.|||0000-0002-2374-9204
  • Bjerke, Maria
  • Engelborghs, Sebastiaan|||0000-0003-0304-9785
  • Jessen, Frank
  • Teunissen, Charlotte E.|||0000-0002-4061-0837
  • Pastor, Pau|||0000-0002-7493-8777
  • Hiltunen, Mikko|||0000-0003-3566-4096
  • Ingelsson, Martin|||0000-0001-5466-8370
  • Andreassen, Ole A.|||0000-0002-4461-3568
  • Clarimón, Jordi|||0000-0002-6824-6942
  • Sleegers, Kristel|||0000-0002-0283-2332
  • Ruiz Laza, Agustín|||0000-0003-2633-2495
  • Ramirez, Alfredo|||0000-0003-4991-763X
  • Cruchaga, Carlos|||0000-0002-0276-2899
  • Lambert, Jean-Charles|||0000-0003-0829-7817
  • van der Flier, Wiesje M.|||0000-0001-8766-6224
Amyloid-beta 42 (Aβ42) and phosphorylated tau (pTau) levels in cerebrospinal fluid (CSF) reflect core features of the pathogenesis of Alzheimer's disease (AD) more directly than clinical diagnosis. Initiated by the European Alzheimer & Dementia Biobank (EADB), the largest collaborative effort on genetics underlying CSF biomarkers was established, including 31 cohorts with a total of 13,116 individuals (discovery n = 8074; replication n = 5042 individuals). Besides the APOE locus, novel associations with two other well-established AD risk loci were observed; CR1 was shown a locus for Aβ42 and BIN1 for pTau. GMNC and C16orf95 were further identified as loci for pTau, of which the latter is novel. Clustering methods exploring the influence of all known AD risk loci on the CSF protein levels, revealed 4 biological categories suggesting multiple Aβ42 and pTau related biological pathways involved in the etiology of AD. In functional follow-up analyses, GMNC and C16orf95 both associated with lateral ventricular volume, implying an overlap in genetic etiology for tau levels and brain ventricular volume.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Characteristics of subjective cognitive decline associated with amyloid positivity

  • Janssen, Olin|||0000-0002-8341-0958
  • Jansen, Willemijn J.
  • Vos, Stephanie J.B.|||0000-0002-2045-9818
  • Boada, Mercè|||0000-0003-2617-3009
  • Parnetti, Lucilla|||0000-0001-5722-3967
  • Gabryelewicz, Tomasz
  • Fladby, Tormod|||0000-0002-9984-9797
  • Molinuevo, José Luis|||0000-0003-0485-6001
  • Villeneuve, Sylvia
  • Hort, Jakub|||0000-0002-1080-3726
  • Epelbaum, Stéphane
  • Lleó, Alberto|||0000-0002-2568-5478
  • Engelborghs, Sebastiaan|||0000-0003-0304-9785
  • van der Flier, Wiesje M.|||0000-0001-8766-6224
  • Landau, Susan
  • Popp, Julius|||0000-0002-0068-0312
  • Wallin, Anders|||0000-0001-9506-0513
  • Scheltens, Philip|||0000-0002-1046-6408
  • Rikkert, Marcel Olde|||0000-0003-1397-1677
  • Snyder, Peter J.|||0000-0003-0555-4654
  • Rowe, Chris
  • Chételat, G.|||0000-0002-4889-7932
  • Ruiz Laza, Agustín|||0000-0003-2633-2495
  • Marquié, Marta|||0000-0002-0660-0950
  • Chipi, Elena
  • Wolfsgruber, Steffen
  • Heneka, Michael|||0000-0003-4996-1630
  • Boecker, Henning|||0000-0003-2346-0598
  • Peters, Oliver|||0000-0003-0568-2998
  • Jarholm, Jonas
  • Rami Gonzalez, Lorena|||0000-0002-7411-1921
  • Tort-Merino, Adrià|||0000-0002-5646-0482
  • Pichet Binette, Alexa|||0000-0001-5218-3337
  • Poirier, Judes
  • Rosa-Neto, Pedro|||0000-0001-9116-1376
  • Cerman, Jiri
  • Dubois, Bruno
  • Teichmann, Marc
  • Alcolea, Daniel|||0000-0002-3819-3245
  • Fortea, Juan|||0000-0002-1340-638X
  • Sánchez-Saudinós, María Belén|||0000-0003-1795-1833
  • Ebenau, Jarith
  • Pocnet, Cornelia
  • Eckerström, Marie
  • Thompson, Louisa
  • Villemagne, Victor
  • Buckley, Rachel|||0000-0002-5356-5537
  • Burnham, Samantha
  • Delarue, Marion
  • Freund-Levi, Yvonne|||0000-0001-6863-6679
  • Wallin, Åsa K.
  • Ramakers, Inez
  • Tsolaki, Magda|||0000-0002-2072-8010
  • Soininen, Hilkka|||0000-0002-2785-9937
  • Hampel, Harald
  • Spiru, Luiza
  • Tijms, Betty M.|||0000-0002-2612-1797
  • Ossenkoppele, Rik
  • Verhey, Frans
  • Jessen, Frank
  • Visser, Pieter Jelle|||0000-0001-8008-9727
Introduction: The evidence for characteristics of persons with subjective cognitive decline (SCD) associated with amyloid positivity is limited. Methods: In 1640 persons with SCD from 20 Amyloid Biomarker Study cohort, we investigated the associations of SCD-specific characteristics (informant confirmation, domain-specific complaints, concerns, feelings of worse performance) demographics, setting, apolipoprotein E gene (APOE) ε4 carriership, and neuropsychiatric symptoms with amyloid positivity. Results: Between cohorts, amyloid positivity in 70-year-olds varied from 10% to 76%. Only older age, clinical setting, and APOE ε4 carriership showed univariate associations with increased amyloid positivity. After adjusting for these, lower education was also associated with increased amyloid positivity. Only within a research setting, informant-confirmed complaints, memory complaints, attention/concentration complaints, and no depressive symptoms were associated with increased amyloid positivity. Feelings of worse performance were associated with less amyloid positivity at younger ages and more at older ages. Discussion: Next to age, setting, and APOE ε4 carriership, SCD-specific characteristics may facilitate the identification of amyloid-positive individuals.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Establishing In-House Cutoffs of CSF Alzheimer's Disease Biomarkers for the AT(N) Stratification of the Alzheimer Center Barcelona Cohort

  • Orellana del Río, Adelina|||0000-0002-0204-1944
  • García-González, Pablo|||0000-0003-0125-5403
  • Valero, Sergi|||0000-0002-6599-948X
  • Montrreal Navarro, Laura|||0000-0002-0010-645X
  • De Rojas, Itziar|||0000-0002-2148-381X
  • Hernández, Isabel|||0000-0001-8119-393X
  • Rosende-Roca, Maitée|||0000-0003-1778-8175
  • Vargas, Liliana|||0000-0001-5685-5903
  • Tartari, Juan Pablo
  • Esteban de Antonio, Ester|||0000-0003-1965-6010
  • Bojaryn, Urszula
  • Narvaiza, Leire
  • Alarcón-Martín, Emilio|||0000-0002-0985-872X
  • Alegret, Montserrat|||0000-0002-8164-9500
  • Alcolea, Daniel|||0000-0002-3819-3245
  • Lleó, Alberto|||0000-0002-2568-5478
  • Tárraga, Lluís|||0000-0002-8423-946X
  • Pytel, Vanesa
  • Cano, Amanda|||0000-0001-9567-4283
  • Marquié, Marta|||0000-0002-0660-0950
  • Boada, Mercè|||0000-0003-2617-3009
  • Ruiz Laza, Agustín|||0000-0003-2633-2495
Background: Clinical diagnosis of Alzheimer's disease (AD) increasingly incorporates CSF biomarkers. However, due to the intrinsic variability of the immunodetection techniques used to measure these biomarkers, establishing in-house cutoffs defining the positivity/negativity of CSF biomarkers is recommended. However, the cutoffs currently published are usually reported by using cross-sectional datasets, not providing evidence about its intrinsic prognostic value when applied to real-world memory clinic cases. Methods: We quantified CSF Aβ1-42, Aβ1-40, t-Tau, and p181Tau with standard INNOTEST® ELISA and Lumipulse G® chemiluminescence enzyme immunoassay (CLEIA) performed on the automated Lumipulse G600II. Determination of cutoffs included patients clinically diagnosed with probable Alzheimer's disease (AD, n = 37) and subjective cognitive decline subjects (SCD, n = 45), cognitively stable for 3 years and with no evidence of brain amyloidosis in 18F-Florbetaben-labeled positron emission tomography (FBB-PET). To compare both methods, a subset of samples for Aβ1-42 (n = 519), t-Tau (n = 399), p181Tau (n = 77), and Aβ1-40 (n = 44) was analyzed. Kappa agreement of single biomarkers and Aβ1-42/Aβ1-40 was evaluated in an independent group of mild cognitive impairment (MCI) and dementia patients (n = 68). Next, established cutoffs were applied to a large real-world cohort of MCI subjects with follow-up data available (n = 647). Results: Cutoff values of Aβ1-42 and t-Tau were higher for CLEIA than for ELISA and similar for p181Tau. Spearman coefficients ranged between 0.81 for Aβ1-40 and 0.96 for p181TAU. Passing-Bablok analysis showed a systematic and proportional difference for all biomarkers but only systematic for Aβ1-40. Bland-Altman analysis showed an average difference between methods in favor of CLEIA. Kappa agreement for single biomarkers was good but lower for the Aβ1-42/Aβ1-40 ratio. Using the calculated cutoffs, we were able to stratify MCI subjects into four AT(N) categories. Kaplan-Meier analyses of AT(N) categories demonstrated gradual and differential dementia conversion rates (p = 9.815). Multivariate Cox proportional hazard models corroborated these findings, demonstrating that the proposed AT(N) classifier has prognostic value. AT(N) categories are only modestly influenced by other known factors associated with disease progression. Conclusions: We established CLEIA and ELISA internal cutoffs to discriminate AD patients from amyloid-negative SCD individuals. The results obtained by both methods are not interchangeable but show good agreement. CLEIA is a good and faster alternative to manual ELISA for providing AT(N) classification of our patients. AT(N) categories have an impact on disease progression. AT(N) classifiers increase the certainty of the MCI prognosis, which can be instrumental in managing real-world MCI subjects.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Differences in macular vessel density in the superficial plexus across cognitive impairment, the NORFACE cohort

  • Marquié, Marta|||0000-0002-0660-0950
  • Valero, Sergi|||0000-0002-6599-948X
  • Martínez, Joan|||0000-0001-7962-709X
  • Alarcón-Martín, Emilio|||0000-0002-0985-872X
  • García-Sánchez, Ainhoa
  • De Rojas, Itziar|||0000-0002-2148-381X
  • Castilla Marti, Miguel|||0000-0003-1886-3536
  • Castilla-Martí, Luis|||0000-0002-7239-5289
  • Hernández, Isabel|||0000-0001-8119-393X
  • Rosende-Roca, Maitée|||0000-0003-1778-8175
  • Vargas, Liliana|||0000-0001-5685-5903
  • Tartari, Juan Pablo
  • Esteban de Antonio, Ester|||0000-0003-1965-6010
  • Bojaryn, Urszula
  • Pytel, Vanesa
  • Narvaiza, Leire
  • Alegret, Montserrat|||0000-0002-8164-9500
  • Ortega Linares, Gemma|||0000-0002-7479-4072
  • Espinosa, Ana|||0000-0001-7399-3267
  • Sanabria, Ángela|||0000-0002-7501-9895
  • Pérez-Cordón, Alba|||0000-0002-6028-0791
  • Lleonart, Núria
  • Muñoz, Nathalia
  • Tárraga, Lluís|||0000-0002-8423-946X
  • Ruiz Laza, Agustín|||0000-0003-2633-2495
  • Boada, Mercè|||0000-0003-2617-3009
Optical coherence tomography angiography (OCT-A) allows the detection of retinal vessel density (VD) loss, which is a reflection of brain vascular pathology. We aimed to investigate differences in macular VD in the superficial plexus in a large cohort of individuals cognitively unimpaired (CU), with mild cognitive impairment due to Alzheimer's disease (MCI-AD), MCI due to cerebrovascular pathology (MCI-Va), probable Alzheimer's disease dementia (ADD) and Vascular Dementia (VaD). Clinical, demographical, ophthalmological and OCT-A data from the Neuro-ophthalmology Research at Fundació ACE (NORFACE) project were analyzed. Differences of macular VD in four quadrants (superior, nasal, inferior and temporal) among the five diagnostic groups were assessed in a multivariate regression model, adjusted by age, sex, education, hypertension, diabetes mellitus, heart disease and stroke. The study cohort comprised 672 participants: 128 CU, 120 MCI-AD, 111 MCI-Va, 257 ADD and 56 VaD. Regression analysis showed a significantly higher VD in the temporal quadrant in MCI-AD compared to CU participants (49.05 ± 4.91 vs 47.27 ± 4.17, p = 0.02, d = 0.40), and a significantly lower VD in the inferior quadrant in MCI-Va compared to CU participants (48.70 ± 6.57 vs 51.27 ± 6.39, p = 0.02, d = 0.40). Individuals with heart disease presented significantly lower VD in the inferior quadrant than those without (p = 0.01). The interaction of sex and diagnosis had no effect in differentiating VD. Mini-Mental State Examination (MMSE) scores were not correlated to VD (all r < 0.16; p.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Proteo-genomics of soluble TREM2 in cerebrospinal fluid provides novel insights and identifies novel modulators for Alzheimer's disease

  • Wang, Lihua
  • Nykänen, Niko-Petteri
  • Western, Daniel|||0000-0003-3725-9553
  • Gorijala, Priyanka
  • Timsina, Jigyasha
  • Li, Fuhai
  • Wang, Zhaohua
  • Ali, Muhammad|||0000-0002-1399-6631
  • Yang, Chengran
  • Liu, Menghan
  • Brock, William
  • Marquié, Marta|||0000-0002-0660-0950
  • Boada, Mercè|||0000-0003-2617-3009
  • Alvarez, Ignacio|||0000-0002-8537-3935
  • Aguilar, Miquel
  • Pastor, Pau|||0000-0002-7493-8777
  • Ruiz Laza, Agustín|||0000-0003-2633-2495
  • Puerta, Raquel|||0000-0002-1191-5893
  • Orellana del Río, Adelina|||0000-0002-0204-1944
  • Rutledge, Jarod
  • Oh, Hamilton
  • Greicius, Michael. D.
  • Le Guen, Yann Le
  • Perrin, Richard J.
  • Wyss-Coray, Tony
  • Jefferson, Angela
  • Hohman, Timothy J.
  • Graff-Radford, Neill
  • Mori, Hiroshi
  • Goate, Alison|||0000-0002-0576-2472
  • Levin, Johannes|||0000-0001-5092-4306
  • Sung, Yun Ju
  • Cruchaga, Carlos|||0000-0002-0276-2899
Triggering receptor expressed on myeloid cells 2 (TREM2) plays a critical role in microglial activation, survival, and apoptosis, as well as in Alzheimer's disease (AD) pathogenesis. We previously reported the MS4A locus as a key modulator for soluble TREM2 (sTREM2) in cerebrospinal fluid (CSF). To identify additional novel genetic modifiers of sTREM2, we performed the largest genome-wide association study (GWAS) and identified four loci for CSF sTREM2 in 3,350 individuals of European ancestry. Through multi-ethnic fine mapping, we identified two independent missense variants (p.M178V in MS4A4A and p.A112T in MS4A6A) that drive the association in MS4A locus and showed an epistatic effect for sTREM2 levels and AD risk. The novel TREM2 locus on chr 6 contains two rare missense variants (rs75932628 p.R47H, P=7.16×10; rs142232675 p.D87N, P=2.71×10) associated with sTREM2 and AD risk. The third novel locus in the TGFBR2 and RBMS3 gene region (rs73823326, P=3.86×10) included a regulatory variant with a microglia-specific chromatin loop for the promoter of TGFBR2. Using cell-based assays we demonstrate that overexpression and knock-down of TGFBR2, but not RBMS3, leads to significant changes of sTREM2. The last novel locus is located on the APOE region (rs11666329, P=2.52×10), but we demonstrated that this signal was independent of APOE genotype. This signal colocalized with cis-eQTL of NECTIN2 in the brain cortex and cis-pQTL of NECTIN2 in CSF. Overexpression of NECTIN2 led to an increase of sTREM2 supporting the genetic findings. To our knowledge, this is the largest study to date aimed at identifying genetic modifiers of CSF sTREM2. This study provided novel insights into the MS4A and TREM2 loci, two well-known AD risk genes, and identified TGFBR2 and NECTIN2 as additional modulators involved in TREM2 biology.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Huntingtin CAG repeats in neuropathologically confirmed tauopathies, Novel insights

  • Pérez-Oliveira, Sergio|||0000-0002-3292-0501
  • Castilla-Silgado, Juan|||0000-0002-6266-8247
  • Painous, Cèlia|||0000-0002-7027-3093
  • Aldecoa, Iban|||0000-0001-5774-7453
  • Mendez-Gonzalez, Manuel|||0000-0002-5218-0774
  • Blázquez Estrada, Marta|||0000-0003-3348-9992
  • Corte, Daniela
  • Tomás-Zapico, Cristina|||0000-0001-7823-0410
  • Compta, Yaroslau|||0000-0001-6443-0104
  • Muñoz García, José Esteban|||0000-0002-0986-1291
  • Llado Plarrumani, Albert|||0000-0002-5066-4150
  • Balasa, Mircea|||0000-0002-1795-4228
  • Aragonès, Gemma
  • García-González, Pablo|||0000-0003-0125-5403
  • Rosende-Roca, Maitée|||0000-0003-1778-8175
  • Boada, Mercè|||0000-0003-2617-3009
  • Ruiz Laza, Agustín|||0000-0003-2633-2495
  • Pastor, Pau|||0000-0002-7493-8777
  • Casa-Fages, Beatriz de la|||0000-0003-0486-3308
  • Rábano, Alberto|||0000-0001-9320-6566
  • Sánchez Valle, Raquel|||0000-0001-7750-896X
  • Molina-Porcel, L.
  • Alvarez, Victoria|||0000-0002-1916-2523
Previous studies have suggested a relationship between the number of CAG triplet repeats in the HTT gene and neurodegenerative diseases not related to Huntington's disease (HD). This study seeks to investigate whether the number of CAG repeats of HTT is associated with the risk of developing certain tauopathies and its influence as a modulator of the clinical and neuropathological phenotype. Additionally, it aims to evaluate the potential of polyglutamine staining as a neuropathological screening. We genotyped the HTT gene CAG repeat number and APOE-ℰ isoforms in a cohort of patients with neuropathological diagnoses of tauopathies (n=588), including 34 corticobasal degeneration (CBD), 98 progressive supranuclear palsy (PSP) and 456 Alzheimer's disease (AD). Furthermore, we genotyped a control group of 1070 patients, of whom 44 were neuropathologic controls. We identified significant differences in the number of patients with pathological HTT expansions in the CBD group (2.7%) and PSP group (3.2%) compared to control subjects (0.2%). A significant increase in the size of the HTT CAG repeats was found in the AD compared to the control group, influenced by the presence of the Apoliprotein E (APOE)-ℰ4 isoform. Post-mortem assessments uncovered tauopathy pathology with positive polyglutamine aggregates, with a slight predominance in the neostriatum for PSP and CBD cases and somewhat greater limbic involvement in the AD case. Our results indicated a link between HTT CAG repeat expansion with other non-HD pathology, suggesting they could share common neurodegenerative pathways. These findings support that genetic or histological screening for HTT repeat expansions should be considered in tauopathies.